ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 99 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13 | -35.0% | 1,944 | 0.0% | 0.00% | – |
Q2 2023 | $20 | +25.0% | 1,944 | 0.0% | 0.00% | – |
Q1 2023 | $16 | -48.4% | 1,944 | 0.0% | 0.00% | – |
Q4 2022 | $31 | -99.9% | 1,944 | 0.0% | 0.00% | – |
Q3 2022 | $31,000 | +14.8% | 1,944 | 0.0% | 0.00% | – |
Q2 2022 | $27,000 | -25.0% | 1,944 | 0.0% | 0.00% | – |
Q1 2022 | $36,000 | +28.6% | 1,944 | 0.0% | 0.00% | – |
Q4 2021 | $28,000 | -20.0% | 1,944 | 0.0% | 0.00% | – |
Q3 2021 | $35,000 | +2.9% | 1,944 | 0.0% | 0.00% | – |
Q2 2021 | $34,000 | -5.6% | 1,944 | -68.0% | 0.00% | – |
Q1 2019 | $36,000 | -16.3% | 6,072 | 0.0% | 0.00% | – |
Q4 2018 | $43,000 | -66.7% | 6,072 | +15.8% | 0.00% | – |
Q4 2017 | $129,000 | +316.1% | 5,242 | +336.8% | 0.00% | – |
Q3 2017 | $31,000 | -3.1% | 1,200 | 0.0% | 0.00% | – |
Q2 2017 | $32,000 | -11.1% | 1,200 | 0.0% | 0.00% | – |
Q1 2017 | $36,000 | +9.1% | 1,200 | 0.0% | 0.00% | – |
Q4 2016 | $33,000 | -46.8% | 1,200 | -50.0% | 0.00% | – |
Q3 2016 | $62,000 | +181.8% | 2,400 | +100.0% | 0.00% | – |
Q2 2016 | $22,000 | – | 1,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |